176 related articles for article (PubMed ID: 16316309)
21. Nursing considerations for clofarabine in the treatment of acute lymphoblastic leukemia in children.
McDonald LR; McCarthy CH
Clin J Oncol Nurs; 2006 Dec; 10(6):809-15. PubMed ID: 17193947
[TBL] [Abstract][Full Text] [Related]
22. Feasibility of clofarabine cytoreduction followed by haploidentical hematopoietic stem cell transplantation in patients with relapsed or refractory advanced acute leukemia.
Tischer J; Stemmler HJ; Engel N; Hubmann M; Fritsch S; Prevalsek D; Schulz C; Zoellner AK; Bücklein V; Hill W; Ledderose G; Hausmann A
Ann Hematol; 2013 Oct; 92(10):1379-88. PubMed ID: 23928857
[TBL] [Abstract][Full Text] [Related]
23. Clofarabine: emerging role in leukemias.
Sampat K; Kantarjian H; Borthakur G
Expert Opin Investig Drugs; 2009 Oct; 18(10):1559-64. PubMed ID: 19715446
[TBL] [Abstract][Full Text] [Related]
24. Clofarabine and nelarabine: two new purine nucleoside analogs.
Gandhi V; Plunkett W
Curr Opin Oncol; 2006 Nov; 18(6):584-90. PubMed ID: 16988579
[TBL] [Abstract][Full Text] [Related]
25. The role of Clofarabine in the treatment of adults with acute myeloid leukemia.
Fozza C
Crit Rev Oncol Hematol; 2015 Mar; 93(3):237-45. PubMed ID: 25457773
[TBL] [Abstract][Full Text] [Related]
26. Clofarabine.
Pui CH; Jeha S
Nat Rev Drug Discov; 2005 May; Suppl():S12-3. PubMed ID: 15962525
[TBL] [Abstract][Full Text] [Related]
27. Clofarabine for the treatment of acute lymphoblastic leukemia.
Jeha S; Kantarjian H
Expert Rev Anticancer Ther; 2007 Feb; 7(2):113-8. PubMed ID: 17288522
[TBL] [Abstract][Full Text] [Related]
28. Clofarabine: in pediatric patients with acute lymphoblastic leukemia.
Curran MP; Perry CM
Paediatr Drugs; 2005; 7(4):259-64; discussion 265-6. PubMed ID: 16117562
[TBL] [Abstract][Full Text] [Related]
29. Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroup.
Huguet F; Leguay T; Raffoux E; Rousselot P; Vey N; Pigneux A; Ifrah N; Dombret H
Leuk Lymphoma; 2015 Apr; 56(4):847-57. PubMed ID: 24996442
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and pharmacodynamics of plasma clofarabine and cellular clofarabine triphosphate in patients with acute leukemias.
Gandhi V; Kantarjian H; Faderl S; Bonate P; Du M; Ayres M; Rios MB; Keating MJ; Plunkett W
Clin Cancer Res; 2003 Dec; 9(17):6335-42. PubMed ID: 14695132
[TBL] [Abstract][Full Text] [Related]
31. Population pharmacokinetics of clofarabine, a second-generation nucleoside analog, in pediatric patients with acute leukemia.
Bonate PL; Craig A; Gaynon P; Gandhi V; Jeha S; Kadota R; Lam GN; Plunkett W; Razzouk B; Rytting M; Steinherz P; Weitman S
J Clin Pharmacol; 2004 Nov; 44(11):1309-22. PubMed ID: 15496649
[TBL] [Abstract][Full Text] [Related]
32. The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemia.
Stumpel DJ; Schneider P; Pieters R; Stam RW
Eur J Cancer; 2015 Sep; 51(14):2008-21. PubMed ID: 26188848
[TBL] [Abstract][Full Text] [Related]
33. Clofarabine in the treatment of elderly patients with acute myeloid leukemia.
Aleem A; Anjum F; Algahtani F; Iqbal Z; Alsaleh K; Almomen A
Asian Pac J Cancer Prev; 2013; 14(2):1089-92. PubMed ID: 23621192
[TBL] [Abstract][Full Text] [Related]
34. Fatal skin and liver toxicity in a patient treated with clofarabine.
Johnston DL; Mandel KM
Pediatr Blood Cancer; 2008 May; 50(5):1082. PubMed ID: 17957757
[No Abstract] [Full Text] [Related]
35. Recent progress in the treatment of acute lymphoblastic leukemia: clofarabine.
Jeha S
Hematol Oncol Clin North Am; 2009 Oct; 23(5):1137-44, viii. PubMed ID: 19825457
[TBL] [Abstract][Full Text] [Related]
36. Successful management with clofarabine for refractory leukaemia in a young adult with chronic renal failure.
Sudour H; Kimmoun A; Contet A; Clement L; Salmon A; Schmitt C; Chastagner P
Am J Hematol; 2011 Mar; 86(3):321-3. PubMed ID: 21328440
[No Abstract] [Full Text] [Related]
37. Nursing considerations for optimal outpatient management of adult patients with leukemia treated with clofarabine.
Dressel A; Kwari M; McGreal AM
Clin J Oncol Nurs; 2011 Feb; 15(1):E13-23. PubMed ID: 21278032
[TBL] [Abstract][Full Text] [Related]
38. Clofarabine induced durable complete remission in heavily pretreated adolescents with relapsed and refractory leukemia.
Steinherz PG; Meyers PA; Steinherz LJ; Jeha S
J Pediatr Hematol Oncol; 2007 Sep; 29(9):656-8. PubMed ID: 17805046
[TBL] [Abstract][Full Text] [Related]
39. Impact of pharmacokinetics on the toxicity and efficacy of clofarabine in patients with relapsed or refractory acute myeloid leukemia.
Büttner B; Knoth H; Kramer M; Oertel R; Seeling A; Sockel K; von Bonin M; Stölzel F; Alakel N; Platzbecker U; Röllig C; Ehninger G; Bornhäuser M; Schetelig J; Middeke JM
Leuk Lymphoma; 2017 Dec; 58(12):2865-2874. PubMed ID: 28509593
[TBL] [Abstract][Full Text] [Related]
40. A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia.
Jabbour E; Short NJ; Ravandi F; Huang X; Xiao L; Garcia-Manero G; Plunkett W; Gandhi V; Sasaki K; Pemmaraju N; Daver NG; Borthakur G; Jain N; Konopleva M; Estrov Z; Kadia TM; Wierda WG; DiNardo CD; Brandt M; O'Brien SM; Cortes JE; Kantarjian H
Cancer; 2017 Nov; 123(22):4430-4439. PubMed ID: 28708931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
